Correspondence 0001493152-25-003359 from Processa Pharmaceuticals, Inc. (PCSA)
Processa Pharmaceuticals, Inc.
Date: Jan. 23, 2025 · CIK: 0001533743 · Accession: 0001493152-25-003359
AI Filing Summary & Sentiment
File numbers found in text: 333-283986
Show Raw Text
CORRESP
1
filename1.htm
January
23, 2025
VIA
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
D.C. 20549
Attention:
Mr. Christopher Edwards
Re:
Processa
Pharmaceuticals, Inc.
Registration
Statement on Form S-1
Registration
No. 333-283986
Ladies
and Gentlemen:
Reference
is made to our letter, dated January 17, 2025, in which we, as Sole Placement Agent for the proposed offering by Processa Pharmaceuticals,
Inc. (the “Company”), joined the Company’s request for acceleration of the effective date of the above-referenced
registration statement (the “Registration Statement”) for January 23, 2025, at 5:00 p.m., Eastern Time. The Company
is no longer requesting that such Registration Statement be declared effective at this time, and we hereby formally withdraw our request
for acceleration of the effective date of the Registration Statement.
Very truly yours,
A.G.P./ALLIANCE GLOBAL PARTNERS
By:
/s/
Thomas J. Higgins
Name:
Thomas J. Higgins
Title:
Managing
Director